|
Initial laboratory data on admission to ED
|
|
Serum hemoglobin, g/dL
|
13.1 ± 2.6
|
15.2 ± 2.2
|
12.6 ± 2.4
|
<0.001
|
|
Platelets (103/µL)
|
181.6 ± 85.5
|
188.6 ± 91.3
|
180.1 ± 84.6
|
0.690
|
|
Serum lactatea, mmol/L
|
12.4 ± 5.3
|
12.6 ± 4.7
|
12.4 ± 5.4
|
0.870
|
|
Arterial pHb
|
7.04 ± 0.20
|
7.08 ± 0.23
|
7.03 ± 0.20
|
0.309
|
|
Serum bicarbonateb, mmol/L
|
16.1 ± 6.1
|
14.3 ± 5.2
|
16.5 ± 6.2
|
0.146
|
|
Base excessb, mmol/L
|
−14.6 ± 6.9
|
−15.3 ± 7.0
|
−14.4 ± 7.0
|
0.636
|
|
Blood urea nitrogen, mg/dL
|
19.6 ± 19.1
|
16.9 ± 6.6
|
20.2 ± 20.9
|
0.493
|
|
Serum creatinine, mg/dL
|
1.6 ± 2.0
|
1.3 ± 0.3
|
1.7 ± 2.2
|
0.495
|
|
AST (IU/L)
|
211 ± 551
|
208 ± 221
|
211 ± 603
|
0.982
|
|
ALT (IU/L)
|
168 ± 509
|
187 ± 224
|
163 ± 555
|
0.847
|
|
Total bilirubin, mg/dL
|
0.6 ± 0.5
|
0.6 ± 0.3
|
0.6 ± 0.5
|
0.760
|
|
aPTT (sec)
|
58.5 ± 45.0
|
52.1 ± 45.5
|
60.0 ± 45.0
|
0.484
|
|
PT (INR)
|
1.63 ± 1.99
|
1.25 ± 0.46
|
1.72 ± 2.19
|
0.340
|
|
SAPS II scoreb
|
92 ± 7
|
88 ± 6
|
93 ± 6
|
0.004
|
|
MAP ≥ 60 mmHg, after ECPR
|
62 (55.9)
|
19 (90.5)
|
43 (47.8)
|
<.001
|
|
Subsequent intervention after ECPR, n (%)
| | | | |
|
Coronary angiography
|
89 (80.1)
|
19 (90.5)
|
70 (77.8)
|
0.238
|
|
Percutaneous coronary intervention
|
59 (53.2)
|
13 (61.9)
|
46 (51.1)
|
0.372
|
|
Therapeutic hypothermia, n (%)
|
31 (27.9)
|
9 (42.9)
|
22 (24.4)
|
0.09
|
|
24-h survival, n (%)
|
63 (56.8)
|
21 (100)
|
42 (46.7)
|
0.002
|
|
Time from arrest to ECPR, min
|
61 (42–88)
|
56 (34–66)
|
67(44–91)
|
0.042
|
|
ECLS duration, h
|
28 (6–58)
|
75 (42–124)
|
19 (4–48)
|
<.001
|
|
Hospital length of stay, days
|
1 (0–6)
|
30 (15–54)
|
0 (0–2)
|
<.001
|
|
Cerebral performance category
| | | |
<.001
|
|
1 or 2
|
17 (15.3)
|
17 (81.0)
|
0
| |
|
3 or 4
|
5 (4.5)
|
4 (19.0)
|
1 (1.1)
| |
|
5 (organ donation)
|
1 (0.9)
|
0
|
1 (1.1)
| |
